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from 20 consecutive patients with acute corotlary occlusion.
Methods
All patients undergoing angioplasty at Emory University Hospital between July 1981 and November 1982 were examined for evidence of acute occlusion after a successful angioplasty. To be included, patients had to have chest pain after angioplasty and either angiographic evidence of complete occlusion at the angioplasty site or ST segment elevation of at least 2 mm in the electrocardiographic lead corresponding to the dilated vessel. In addition, the initial angiographic and pressuregradient response must have been judged to be satisfactory, i.e., the diameter narrowing must have been reduced by at least 20% and the pressure gradient across the stenosis coirrespondingly reduced. Twenty of 935 patients met these criteria during this period. The basic method of angioplasty has been described previously. 6 7 The following is a list of certain details germane to the treatment of acute occlusion.
(1) All patients receive 10,000 units of heparin ihtravenously as soon as both the pacing catheter and guiding catheter are in place. An additional 5000 units of heparin is given 1 hr later if angioplasty is not cornpleted by that time.
(2) Heparin is never neutralized by the adnlinistration of protamine sulfate. Arterial and venous sheaths are left in the puncture site for 2 to 3 hr after angioplasty. ( No major local arterial problems have been observed when the sheaths have been removed by 4 hr after angioplasty.) (3) Nitroglycerin, 0.4 mg, and nifedipine, 10 mg, are administered sublingually at the beginning of the procedure.
(4) Intracoronary nitroglycerin, 100 to 200 mg/ml, is administered just before crossing the lesion. This is repeated when the operator believes it necessary. ed in figure 1. Of these 20 patients, 11 (55%) had left anterior descending artery (LAD) lesions, six (30%) had right coronary artery (RCA) lesions, and three (15%) had circumflex artery lesions. During this period, 64% of the total number of patients were treated for LAD lesions, 26% were treated for RCA lesions, and 10% were treated for circumflex artery lesions. In 16 patients, acute occlusion was demonstrated with coronary angiography and in 11 it was suggested by electrocardiographically measured ECG ST segment elevation of more than 2 mm. Seven patients met both criteria. In 16 patients the onset of symptoms occurred after they left the cardiac catheterization laboratory. In these 20 patients the mean diameter narrowing was reduced from 74 + 15% to 23 + 11% and the mean pressure gradient was reduced from 52 + 15 to 11 ± 8 mm Hg. Four of five patients undergoing surgery had electrographic (ECG) evidence of infarction. Two of these 20 patients (Nos. 4 and 14) were undergoing repeat angioplasty for recurrent stenosis.
Fourteen of these 20 patients demonstrated acute occlusion within 3 hr of an otherwise successful coronary angioplasty. Of the other six patients, three (Nos. 1, 5, and 17) developed acute occlusion within 3 hr after being weaned from continuous heparin infusions. Patients 2 and 9 had angina less than 2 hr after PTCA, but initial normal (unchanged) ECGs led to false-negative diagnoses. From a second ECG recorded the following morning a diagnosis of infarction was possible in patient 2, but in patient 9, who had good collateral vessels, a repeat catheterization performed to investigate patency before a second vessel PTCA was necessary to obtain the diagnosis.
The only patient who demonstrated onset of inclusion criteria later than 3 hr after stopping heparin was patient 16 . This patient experienced a vagal reaction associated with hypotension and bradycardia followed by chest pain at 16 hr after PTCA. This was also the only patient who fulfilled angiographic criteria for coronary thrombosis.9
The most prominent predisposing factor to acute occlusion is the presence of an intimal tear. This is manifested angiographically as a double line present on the angiogram. This angiographic finding was present in 14 of these 20 patients (70%). Three Only sublingual nitrates, nifedipine, and repeat boluses of heparin were given. All three had elevated enzyme levels, but the ECG criteria for infarction were not met. In 11 patients repeat angioplasty was attempted and it reopened the artery, relieved the chest pain, and reversed the ST segment elevation in eight patients. In one patient the syndrome was transient; repeat PTCA was necessary every 10 min to keep the vessel from reoccluding. In one patient the lesion could not be recrossed and in another an attempt to recross resulted in coronary artery dissection.
Intracoronary nitroglycerin alone reopened the vessel in three patients (Nos. 5, 18, and 20). In patient 5 this relief was transient. Repeat bolus infusions were required every 5 min to prevent recurrence of occlusion. Streptokinase was given to three patients (1, 14, 728 and 16); in one of these three (16) streptokinase was judged to be useful in resolving the arterial occlusion.
Discussion
The treatment these patients received represents a significant departure from that previously used; there was a time when all patients with acute occlusion underwent emergency bypass surgery. The. discovery that most of these patients, once their arteries were reopened, could be stabilized with 24 hr continuous intravenous infusions of heparin and nitroglycerin has allowed safe treatment without bypass surgery.
To be included in this study patients had to have had a satisfactory initial result from angioplasty. In 16 of the study patients the onset of symptoms occurred after they left the cardiac catheterization laboratory. For this PATHOPHYSIOLOGY AND NATURAL HISTORY-PTCA ence with this technique and patient 17 did not receive counterpulsation for logistic reasons.
Creatine kinase levels were elevated in 12 patients. These values might be higher than would be expected after a traditionally treated myocardial infarction because of the washout phenomena associated with reperfusion. 8 The benign clinical course in these patients after their arteries were reopened suggests that the infarctions were small and of no clinical consequence.
Mechanism of acute occlusion. The mechanisms of acute occlusion may well be multiple. It is not possible to definitely distinguish between coronary spasm, coronary thrombosis, and subintimal hemorrhage by angiographic criteria. Schoffer et al.3 suggested that acute occlusion was due to coronary thrombosis because three of their patients responded to intracoronary streptokinase and discontinuation of the infusion was associated with reclosure in one patient. Our study differs from that of Schoffer et al. in that all our patients had undergone elective PTCA and in all the procedure was initially successful. In their study PTCA was performed immediately after successful streptokinase recanalization of an acute myocardial infarction in one patient and another patient in their group did not have any balloon inflations but had arterial closure associated with attempted passage of the dilatation catheter. All the occlusions they observed occurred while the patients were still in the catheterization laboratory. Sixteen of our patients had left the laboratory. As additional evidence for coronary thrombosis, these authors cite the work of Block et al. 4 in which coronary thrombosis at the site of PTCA was demonstrated at autopsy of two patients who died after PTCA and emergency coronary bypass surgery.
There are several reasons to question the diagnosis of coronary thrombosis. First, all patients in our series were pretreated with aspirin and heparin. Second, angiographic evidence of thrombosis was demonstrated in only one patient in whom occlusion was observed 16 hr after successful PTCA. In a prospective study of patients with acute myocardial infarction, DeWood et al.9 found thrombus to be present at surgery in 88.1% of patients in whom thrombus was demonstrated angiographically. Moreover, only five of 20 patients (25%) had thromboses at surgery that were not apparent on their angiograms. Since the lumens of these vessels were relatively open (residual diameter narrowing 23 ± 1 1%), it is unlikely that a thrombus large enough to occlude these vessels would escape angiographic detection. 10 Intra-arterial thrombi tend to form in vessels with slow flow; the minimal residual pressure gradient of 11 + 8 mm Hg by itself would not plasty. In vasospastic angina thromboxane inhibition has failed to decrease the number of attacks. " Our patients all received aspirin (650 mg) the night before angioplasty, and this should have inhibited thromboxane production. '7 In patients with unstable angina, it is not known whether the associated elevation of thromboxane in the coronary sinus is a primary or secoridary event.'8 Similarly, in those with acute occlusion the thromboxane elevation may be a primary or a secondary event. Perhaps such a release is important only in the perpetuation of occlusion.
The presence of an intimal tear that is visible angiographically may mean that a large amount of collagen is exposed to platelets. In any case, because of these observations, we now place all patients with a large intimal tear on their post-PTCA control angiograms on continuous intravenous infusions of nitroglycerin and heparin for at least 24 hr.
Coronary occlusion occurs in about 2% of patients undergoing successful angioplasty. Most patients present within 3 hr after receiving 10,000 units of heparin or within 3 hr after the discontinuation of a heparin infusion. Although bypass surgery is required in some patients, in most patients acute occlusion can be reopened with nitrates, calcium antagonists, or repeat angioplasty. Once acute occlusion has been resolved, patients may be effectively stabilized with continuous infusions of nitroglycerin and heparin. The mechanism of acute occlusion is still not precisely known, but it is doubtful that occluding thrombosis plays a significant role. It is more likely that acute occlusion represents a refractory form of local coronary arterial spasm.
